Patents Assigned to DiObex, Inc.
  • Publication number: 20100280046
    Abstract: Pharmaceutical compositions comprising the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2R,4S ketoconazole enantiomer are useful to reduce testosterone synthesis and for the treatment of prostate cancer, benign prostatic hyperplasia, seborrhea, hirsutism, alopecia, polycystic ovary syndrome, and other diseases and conditions, including but not limited to systemic hyperandrogenism.
    Type: Application
    Filed: January 9, 2007
    Publication date: November 4, 2010
    Applicant: DIOBEX, INC.
    Inventor: Timothy Andrew Stewart
  • Patent number: 7683027
    Abstract: Provided are methods of administering glucagon so as to reduce the risk of hypoglycemic unawareness. Also provided are methods of returning hypoglycemic awareness to a subject.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: March 23, 2010
    Assignee: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Patent number: 7678762
    Abstract: Pharmaceutical compositions comprising glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia. Also provided are methods of administering glucagon so as to reduce the risk of hypoglycemia.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: March 16, 2010
    Assignee: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Patent number: 7678763
    Abstract: Pharmaceutical compositions comprising glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia. Also provided are methods of administering glucagon so as to reduce the risk of inducing hypoglycemia.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: March 16, 2010
    Assignee: Diobex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Patent number: 7655618
    Abstract: Pharmaceutical compositions comprising glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia. Also provide are methods of administering glucagon so as to reduce the risk of inducing hypoglycemia.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: February 2, 2010
    Assignee: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Patent number: 7642232
    Abstract: Pharmaceutical composition comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: January 5, 2010
    Assignee: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Publication number: 20080166399
    Abstract: Pharmaceutical compositions comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.
    Type: Application
    Filed: October 29, 2007
    Publication date: July 10, 2008
    Applicant: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Publication number: 20080160072
    Abstract: Pharmaceutical compositions comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.
    Type: Application
    Filed: October 29, 2007
    Publication date: July 3, 2008
    Applicant: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Publication number: 20080160073
    Abstract: Pharmaceutical compositions comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.
    Type: Application
    Filed: October 29, 2007
    Publication date: July 3, 2008
    Applicant: DiObex, Inc.
    Inventors: Daniel T. Green, Robert R. Henry
  • Publication number: 20080096801
    Abstract: Pharmaceutical composition comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.
    Type: Application
    Filed: December 21, 2007
    Publication date: April 24, 2008
    Applicant: DiObex, Inc.
    Inventors: Daniel Green, Robert Henry
  • Patent number: 7314859
    Abstract: Pharmaceutical composition comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: January 1, 2008
    Assignee: DiObex, Inc.
    Inventors: Daniel T Green, Robert R. Henry